Thymic carcinoma diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) |
Shyam Patel (talk | contribs) |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The | The diagnostic study of choice for thymic carcinoma is tissue biopsy. | ||
==Diagnostic study of choice== | ==Diagnostic study of choice== |
Revision as of 04:50, 10 February 2019
Thymic Carcinoma Microchapters |
Diagnosis |
---|
Case Studies |
Thymic carcinoma diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Thymic carcinoma diagnostic study of choice |
Risk calculators and risk factors for Thymic carcinoma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [3]
Overview
The diagnostic study of choice for thymic carcinoma is tissue biopsy.
Diagnostic study of choice
The diagnostic study of choice for thymic carcinoma is tissue biopsy.[1]
References
- ↑ Akiyama T, Miyamoto Y, Nomoto D, Kiyozumi Y, Eto K, Hiyoshi Y; et al. (2019). "Laparoscopic dissection for pelvic lymph node recurrence of thymic carcinoma: A case report". Asian J Endosc Surg. doi:10.1111/ases.12688. PMID 30714349.